Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate

S. Bangaru, G. Ozorowski, H. Turner, A. Antanasijevic, Deli Huang, Xiaoning Wang, J. Torres, J. Diedrich, J. Tian, Alyse D. Portnoff, N. Patel, M. Massare, J. Yates, D. Nemazee, J. Paulson, G. Glenn, Gale Smith, A. Ward

Science, 2020

Structure of a vaccine candidate Much effort is being targeted at developing vaccines that will provide protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A trimeric spike protein that decorates the virus is a primary target of the host immune system and the focus of vaccine development. Bangaru et al. present the structure of a leading vaccine candidate: a full-length spike protein with some modifications aimed at enhancing stability that is formulated in polysorbate 80 detergent. The study confirms that the full-length immunogen is in a stable prefusion conformation and provides a basis for understanding immune responses to the vaccine. Science, this issue p. 1089 Cryo-EM and glycan analysis of a leading SARS-CoV-2 subunit vaccine candidate reveals a stable prefusion conformation of the spike immunogen. Vaccine efforts to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for the current coronavirus disease 2019 (COVID-19) pandemic, are focused on SARS-CoV-2 spike glycoprotein, the primary target for neutralizing antibodies. We performed cryo–election microscopy and site-specific glycan analysis of one of the leading subunit vaccine candidates from Novavax, which is based on a full-length spike protein formulated in polysorbate 80 detergent. Our studies reveal a stable prefusion conformation of the spike immunogen with slight differences in the S1 subunit compared with published spike ectodomain structures. We also observed interactions between the spike trimers, allowing formation of higher-order spike complexes. This study confirms the structural integrity of the full-length spike protein immunogen and provides a basis for interpreting immune responses to this multivalent nanoparticle immunogen.

Cited by 47 publications.

Field of study: Chemistry

10.1126/science.abe1502